Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-21-004457
Accepted
2021-11-24 00:15:09
Documents
1
Effectiveness Date
2021-11-23
Registration Form
POS AM
Reference AccNo
0001493152-21-029260

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 610
  Complete submission text file 9999999995-21-004457.txt   1844
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: EFFECT | Act: 33 | File No.: 333-234292 | Film No.: 211441076
SIC: 2834 Pharmaceutical Preparations